The Cooper Companies, Inc. (COO)
| Market Cap | 16.18B |
| Revenue (ttm) | 4.09B |
| Net Income (ttm) | 374.90M |
| Shares Out | 198.81M |
| EPS (ttm) | 1.87 |
| PE Ratio | 43.53 |
| Forward PE | 18.10 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 10,745,649 |
| Open | 89.66 |
| Previous Close | 77.03 |
| Day's Range | 80.89 - 89.83 |
| 52-Week Range | 61.78 - 104.47 |
| Beta | 1.05 |
| Analysts | Buy |
| Price Target | 85.82 (+5.43%) |
| Earnings Date | Dec 4, 2025 |
About COO
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women’s health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cor... [Read more]
Financial Performance
In 2025, The Cooper Companies's revenue was $4.09 billion, an increase of 5.06% compared to the previous year's $3.90 billion. Earnings were $374.90 million, a decrease of -4.44%.
Financial StatementsAnalyst Forecast
According to 11 analysts, the average rating for COO stock is "Buy." The 12-month stock price target is $85.82, which is an increase of 5.43% from the latest price.
News
Cooper Companies Launches Portfolio Review To 'Unlock Value'
Cooper Companies (NASDAQ: COO) stock rose Friday after the company reported better-than-expected fourth-quarter earnings and upbeat financial guidance.
The Cooper Companies, Inc. (COO) Q4 2025 Earnings Call Transcript
The Cooper Companies, Inc. (COO) Q4 2025 Earnings Call Transcript
Cooper Companies initiates strategic review; shares jump
Medical device maker Cooper Companies said it is initiating a formal strategic review aimed at identifying opportunities to enhance long-term shareholder value, sending shares up 11.7% in extended tra...
CooperCompanies Announces New Chair of the Board and Strategic Review
SAN RAMON, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today that its Board of Directors has appointed Colleen Jay to succeed c...
CooperCompanies Announces Fourth Quarter and Full Year 2025 Results
SAN RAMON, Calif., Dec. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today financial results for its fiscal fourth quarter and full ye...
Cooper Companies Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
The Cooper Companies, Inc. (NASDAQ: COO) will release earnings results for the fourth quarter after the closing bell on Thursday, Dec. 4.
Browning West Delivers Letter to The Cooper Companies Board of Directors
Cooper's Lack of Strategic Focus, Misaligned Incentives, and Inadequate Board Oversight Have Led to Meaningful Underperformance
Jana Partners push to break up Cooper Cos. could change the stock's outlook
Jana announced a top portfolio position in Cooper and plans to push for strategic alternatives, including a potential combination for its contact lens unit.
CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2025
SAN RAMON, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report fourth quarter and full year 2025 financial results...
Overlooked Stock: Activist Investor Taps COO Amid 30% Y/Y Slide
Shares of Cooper Companies (COO) rallied on Monday's session as an activist investor eyes a turnaround. Reports say Jana Partners is pushing for the company to merge with Bausch + Lomb (BLCO) among ot...
Activist investor Jana Partners takes stake in medical device maker Cooper Companies, WSJ says
The hedge fund will push Cooper to improve how it allocates capital in order to boost returns, the WSJ said.
Activist Jana Takes Stake in Cooper, a Maker of Medical Devices
Bausch + Lomb is seen as a potential buyer for the contact-lens unit and the CEO said he would be interested.
The Cooper Companies: Defensive Gem With Insider Buying And Building Momentum
Cooper Companies may strongly outperform the S&P 500 going forward, especially in a recessionary environment, rebounding from 2025's sell-off. COO trades at decade-low enterprise valuations, with rene...
CooperCompanies Announces Expanded Share Repurchase Program
SAN RAMON, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today its Board of Directors has approved a $1 billion increase ...
The Cooper Companies, Inc. (COO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
The Cooper Companies, Inc. (NASDAQ:COO) Wells Fargo 20th Annual Healthcare Conference 2025 September 3, 2025 3:00 PM EDT Company Participants Albert White - President, CEO & Non-Independent Director ...
Stock Of The Day: Time To Buy Cooper Companies?
Cooper Companies, Inc. COO is trading higher on Friday. There is a chance that the stock goes into a new uptrend.
Why Cooper Companies Stock Sank by 13% Today
The stock of medical device specialist Cooper Companies (COO 0.13%) was hurting on the second-to-last trading day of the week. It sank to a 13% loss on the day, following the publication of the compan...
The Cooper Companies, Inc. (COO) Q3 2025 Earnings Call Transcript
The Cooper Companies, Inc. (NASDAQ:COO) Q3 2025 Earnings Conference Call August 27, 2025 5:00 PM ET Company Participants Albert G. White - President, CEO & Non-Independent Director Brian G.
Cooper Companies Posts Downbeat Sales, Joins NetApp, Urban Outfitters, Nvidia And Other Big Stocks Moving Lower In Thursday Pre-Market Session
U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Thursday.
CooperCompanies Announces Third Quarter 2025 Results
SAN RAMON, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal third quarter ended July 3...
CooperCompanies to Participate in the Wells Fargo Healthcare Conference
SAN RAMON, Calif., Aug. 14, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will participate in the Wells Fargo Healthcare Conferenc...
Cooper Companies Q3 Preview: Low Fertility Growth During Year Of Snake Is Temporary
Cooper Companies Q3 Preview: Low Fertility Growth During Year Of Snake Is Temporary
Baron Health Care Fund Q2: Top Contributors, Misses, And Strategic Shifts
Insmed, Intuitive Surgical, and IDEXX Laboratories were top contributors, driven by strong drug pipelines, innovation, and robust financial results. We exited UnitedHealth Group due to earnings misses...
Nuclear Sector Earnings Show a Mixed Picture. Why One Stock Is Surging.
There's a long way to go before the expected nuclear renaissance becomes a reality.
CooperCompanies Announces Release Date for Third Quarter 2025
SAN RAMON, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report third quarter 2025 financial results on Wednesday, ...